MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fonc.2025.1667939

Медицинская библиотека · Frontiers in oncology · 2025

Nomogram for predicting risk of arm lymphedema following axillary lymph node dissection in breast cancer patients.

Jia Miaomiao, Pan Lihui, Yang Haibo, Gao Jinnan, Shen Wenzhuang, Zhang Xiaojun

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: Breast cancer-related arm lymphedema (BCRaL) is a prevalent and severe complication post-breast cancer treatment, especially following axillary lymph node dissection (ALND). This study aimed to develop a nomogram for BCRaL risk prediction by identifying and integrating key risk factors, including chemotherapy type (neoadjuvant vs. adjuvant), to enhance individualized patient monitoring and prevention strategies.

PATIENTS AND

METHODS

We conducted a retrospective analysis of clinical data from 535 breast cancer patients who received ALND and chemotherapy. Patients were divided into a training cohort (70%) and a validation cohort (30%). Univariate and multivariate Cox regression analyses identified independent risk factors for BCRaL, which were subsequently used to construct a nomogram. The model's performance was assessed through calibration curves, ROC curves, and clinical decision curve analysis (DCA).

RESULTS

The incidence of BCRaL in our cohort was 20.6%. Multivariate analysis identified several independent risk factors for BCRaL, including elevated body mass index (BMI), increased number of positive axillary lymph nodes, neoadjuvant chemotherapy (NAC), HER2-targeted therapy, and supraclavicular radiotherapy (SCRT). The nomogram developed based on these factors demonstrated strong predictive accuracy, with C-index values of 0.692 in the training cohort and 0.719 in the validation cohort. ROC curve analysis revealed AUC values reaching 0.760, indicating good discriminative ability. Time-dependent ROC curves further confirmed the model's consistency across different follow-up periods. DCA validated the clinical utility of the nomogram, while survival analysis clearly distinguished between high-risk and low-risk BCRaL groups.

CONCLUSION

This study developed and internally validated a predictive model that integrates modern treatment modalities (NAC, HER2-targeted therapy, SCRT) with traditional risk factors to identify high-risk BCRaL patients undergoing ALND and chemotherapy. The model requires external validation in future studies. Consequently, the nomogram presents a potential tool for strategizing precision prevention, necessitating further evaluation before its broader adoption in clinical practice.

Для цитирования: Jia Miaomiao, Pan Lihui, Yang Haibo, Gao Jinnan, Shen Wenzhuang, Zhang Xiaojun. Nomogram for predicting risk of arm lymphedema following axillary lymph node dissection in breast cancer patients.. Frontiers in oncology. 2025. DOI: 10.3389/fonc.2025.1667939.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.